These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Biederman J, Swanson JM, Wigal SB, Kratochvil CJ, Boellner SW, Earl CQ, Jiang J, Greenhill L. Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134 [Abstract] [Full Text] [Related]
5. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion. Faraone SV, Wilens TE. J Clin Psychiatry; 2007 Dec; 68 Suppl 11():15-22. PubMed ID: 18307377 [Abstract] [Full Text] [Related]
6. Attention deficit/hyperactivity disorder across the lifespan. Wilens TE, Biederman J, Spencer TJ. Annu Rev Med; 2002 Dec; 53():113-31. PubMed ID: 11818466 [Abstract] [Full Text] [Related]
14. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study. Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK. Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731 [Abstract] [Full Text] [Related]
17. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study. van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM. Clin Psychol Psychother; 2012 Jun; 19(3):270-8. PubMed ID: 21404369 [Abstract] [Full Text] [Related]
18. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Pliszka S, AACAP Work Group on Quality Issues. J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):894-921. PubMed ID: 17581453 [Abstract] [Full Text] [Related]
19. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder. Winterstein AG, Gerhard T, Shuster J, Johnson M, Zito JM, Saidi A. Pediatrics; 2007 Dec; 120(6):e1494-501. PubMed ID: 18055666 [Abstract] [Full Text] [Related]
20. Can we prevent smoking in children with ADHD: a review of the literature. Modesto-Lowe V, Danforth JS, Neering C, Easton C. Conn Med; 2010 Apr; 74(4):229-36. PubMed ID: 20441004 [Abstract] [Full Text] [Related] Page: [Next] [New Search]